Analyst Ratings for Synthetic Biologics (SYN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2021 | Maxim Group » Updated 8/11/2022 |
Jason McCarthy | Upgrade | Buy (Hold) |
4.00 (10.00) |
0.92 (1.02) |
10.87% | Details |
| 5/18/2018 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
1.00 (N/A) |
0.25 (1.02) |
308% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
